This is the annual report of the NBA for the 2010–11 financial year. It also includes the NBA Board annual report for the same period.
Presents a high level view of the sector, its stakeholders and the blood products used, and describes the NBA’s objectives.
Identifies key statistics and major achievements during the year, and presents reports of the NBA’s General Manager, Principal Medical Officer and the annual report of the NBA Board.
Summarises the NBA’s outcome and program structure and reports on the NBA’s performance against the key performance indicators and qualitative and quantitative deliverables established in the 2010–11 Portfolio Budget Statements.
Describes the external influences that could affect the way the NBA does business in the future. It provides a summary of the core developments we have monitored during 2010–11, including factors that may affect global supply, demand and pricing, donor and product safety issues and international regulatory trends.
Includes information on corporate governance, planning and service delivery, people management, audit arrangements and how we manage risk and fraud.
Discusses the NBA’s budget, financial and asset management and purchasing arrangements, and presents the audited financial statements.
Contains additional information to further explain material in the body of the report such as the government’s objectives under the National Blood Agreement, the NBA’s agency resource statement, further information about NBA stakeholders, lists of blood and blood products supplied under contract, biographies of NBA Board members and the NBA’s senior management team, further information about fresh blood component supply by state and territory, mandatory reporting on a number of government policies, errata, acronyms and a glossary of terms, and a list of requirements.